| Name | CCN family member 2 | ||
| UniProt ID | CCN2_HUMAN | ||
| Gene Name | CCN2 | ||
| Gene ID | 1490 | ||
| Synonyms |
CCN2, CTGF, HCS24, IBP-8, IGFBP8, NOV2
|
||
| Sequence |
MTAASMGPVRVAFVVLLALCSRPAVGQNCSGPCRCPDEPAPRCPAGVSLVLDGCGCCRVC
AKQLGELCTERDPCDPHKGLFCHFGSPANRKIGVCTAKDGAPCIFGGTVYRSGESFQSSC KYQCTCLDGAVGCMPLCSMDVRLPSPDCPFPRRVKLPGKCCEEWVCDEPKDQTVVGPALA AYRLEDTFGPDPTMIRANCLVQTTEWSACSKTCGMGISTRVTNDNASCRLEKQSRLCMVR PCEADLEENIKKGKKCIRTPKISKPIKFELSGCTSMKTYRAKFCGVCTDGRCCTPHRTTT LPVEFKCPDGEVMKKNMMFIKTCACHYNCPGDNDIFESLYYRKMYGDMA |
||
| Pathway Map | MAP LINK | ||
| T.C. Number | 1.A.6.1.10; 1.A.6.1.2; 8.B.10.1.1 | ||
| KEGG ID | hsa1490 | ||
| TTD ID | T29036 | ||
| Pfam | PF00007; PF00090; PF00093; PF00219; PF19035 | ||
| Pair Name | Ursolic acid, Doxorubicin | |||
| Phytochemical | Ursolic acid | |||
| Drug | Doxorubicin | |||
| Disease Info | [ICD-11: 2B91] | Colorectal cancer | Investigative | |
| Regulate Info | Down-regulation | CCN family member 2 | Expression | |
| Result | UA may be a novel anticancer strategy and could be considered for investigation as a complementary chemotherapy agent in the future. | |||
